← Back to Patent Explorer
US4409223A Expired / Lapsed US ⏱️ 0.0 years remaining

Anxiolytic method

Assignee: Bristol Myers Co
•
Filing: 1982-08-06
•
Granted: 1983-10-11
•
Expires: 2002-08-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1-(2-Pyrimidinyl)piperazine and its pharmaceutically acceptable salts are useful in the alleviation of anxiety.

Inventors

  • 👤 Leslie A. Riblet
  • 👤 Michael S. Eison

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 21:18
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/505

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 38 words
The process for ameliorating an anxiety state in a mammal in need of such treatment comprising systemic administration to said mammal of an effective but non-toxic anxiolytic dose of 1-(2-pyrimidinyl)piperazine or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 38 words
The process for ameliorating an anxiety state in a mammal in need of such treatment comprising systemic administration to said mammal of an effective but non-toxic anxiolytic dose of 1-(2-pyrimidinyl)piperazine or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 45 words
The process of claim 1 wherein a pharmaceutical composition in unit dosage form suitable for systemic administration to a mammalian host is utilized which comprises a pharmaceutical carrier and an effective anxiolytic but non-toxic amount of 1-(2-pyrimidinyl)piperazine or a pharmaceutically acceptable acid addition salt thereof.
Claim 4
Dependent Claim 33 words
The process of claim 2 wherein said pharmaceutical composition comprises an amount of 1-(2-pyrimidinyl)piperazine to provide an effective anxiolytic but non-toxic dose of from 0.1 to 40 mg/kg body weight of said host.

References Cited (Backward Citations)

US3717634A Cited
US3907801A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-10-10 1987-04-11 1987-10-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-10-10 1991-04-11 1991-10-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-10-10 1995-04-11 1995-10-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag